Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kristin Cabeda

Physician Assistant Charlotte, NC Physician Assistant

NPI 1487944468 CMS profile 10774644

1237 Harding Pl, Ste 3100, Charlotte, NC 28204

Open in the dashboard

General payments

$135,258

288 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kristin Cabeda of Charlotte, NC is reported in the CMS Open Payments database as having received $135,258 across 288 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $49,731 74
2024 General $75,375 111
2023 General $463 34
2022 General $6,759 54
2021 General $2,930 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kristin Cabeda
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kristin Cabeda were reported at $49,731. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kristin Cabeda Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,930 $132 $37–$438 $132
2022 $6,759 $155 $48–$522 $149
2023 $463 $167 $52–$557 $160
2024 $75,375 $178 $55–$600 $164
2025 $49,731 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Galderma Laboratories, L.P. $124,863 195 payments
  2. Allergan Inc. $8,324 37 payments
  3. AbbVie, Inc. $1,199 37 payments
  4. Merz North America, Inc. $710 13 payments
  5. Musculoskeletal Transplant Foundation Inc. $78 2 payments
  6. Masimo Corporation $68 3 payments
  7. Revance Therapeutics, Inc. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125,100 57 payments
  2. Food and Beverage $4,660 182 payments
  3. Travel and Lodging $4,458 47 payments
  4. Consulting Fee $1,040 2 payments
Products named General payments · program years 2021–2025
  1. BOTOX $1,653 55 payments
  2. DYSPORT $484 28 payments
  3. DYSPORT $231 18 payments
  4. Patient SafetyNet System $68 3 payments
  5. Xeomin $38 1 payment
  6. DAXXIFY $16 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

288 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record